Baird Medical Lands Exclusive China Resources Distribution Deal With $900K Initial Order
BDMD is trading near its 52-week low of $0.133 (13% above the low) on elevated volume (38× avg).
Summary
Baird Medical's PRC subsidiary signed China Resources Pharmaceutical Commercial Group Medical Devices as exclusive distributor of its microwave ablation products across 19 Chinese markets, targeting regions where Baird has had little direct commercial presence. The agreement came with an initial order of roughly RMB 6 million ($900,000) at signing. That order is meaningful against a company that reported H1 2026 revenue of $9.9 million, and it puts a large state-backed distribution network behind the product in China. The deal does not fix the balance sheet: Baird has been funding itself through a highly dilutive convertible note and disclosed a going-concern assessment resolved only by a $2.0M support letter from its CEO. The commercial validation is real, but dilution and liquidity remain the dominant facts for the equity.
At the time of this announcement, BDMD was trading at $0.15 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $5.1M. The 52-week trading range was $0.13 to $3.70. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: GlobeNewswire.